Summary of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2014

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

In thousands)	For the Three Months Ended December 31,				For the Six Months Ended December 31,
Medical Indication	2014		2013		2014		2013
Antibiotic	$	3,346	$	4,334	$	6,349	$	7,708
Cardiovascular	18,333		16,923		37,272		21,448
Gallstone	16,719		1,136		28,480		2,502
Glaucoma	5,516		1,482		10,207		2,936
Gout	2,990		2,009		5,289		4,062
Migraine	6,938		2,349		12,733		5,064
Obesity	953		844		1,868		1,975
Pain Management	7,567		6,793		14,222		12,011
Thyroid Deficiency	44,535		26,241		77,881		46,268
Other	7,925		5,215		13,908		9,181
Total	$	114,822	$	67,326	$	208,209	$	113,155

Summary of products which accounted for at least 10% of net sales

	For the Three Months Ended December 31,				For the Six Months Ended December 31,
	2014		2013		2014		2013
Product 1	39	%	39	%	37	%	41	%
Product 2	15	%	22	%	16	%	15	%
Product 3	15	%	2	%	14	%	2	%

Summary of customers which accounted for at least 10% of net sales

	For the Three Months Ended December 31,				For the Six Months Ended December 31,
	2014		2013		2014		2013
Customer A	31	%	23	%	31	%	20	%
Customer B	7	%	12	%	8	%	10	%
Customer C	0	%	15	%	0	%	15	%